NAR CancerCancer BiologyPeer-reviewed journal article
Automated Machine Learning Profiling with MAP-HR for Quantifying Homologous Recombination Foci in Patient Samples
Tugba Y. OzmeniD, Matthew J. RamesiD, Gabriel Mesquita ZangirolaniiD, Furkan OzmeniD, Kangjin JeongiD, Connor Mitchell Frankston, Gordon Brent MillsiD
Abstract
Accurate visualization and quantification of homologous recombination (HR)-associated foci in readily available patient samples are critical for identifying patients with HR deficiency (HRD) when they present for care to guide polyADP ribose polymerase (PARP) inhibitors (PARPi) or platinum-based therapies. Immunofluorescence (IF) assays have the potential to accurately visualize DNA repair processes as punctate foci within the nucleus. To ensure precise HRD assessment, we developed MAP-HR, (Machine-learning Assisted Profiling of Homologous Recombination), a scalable machine-learning (ML) analysis platform to enable effective patient triage and therapeutic decision-making. This workflow integrates high-resolution four-channel IF imaging and automated analysis of Geminin (cell cycle states), RAD51 (HR repair),{gamma} H2AX foci (double strand breaks) and DAPI (nuclear localization) in both cultured cell lines and in a single formalin-fixed, paraffin-embedded (FFPE) patient sample. Using a spinning disk confocal microscope, we optimized imaging parameters to improve resolution and signal-to-noise ratio. Our MAP-HR pipeline uses nested nuclei and segmentation of foci to analyze the HR status of each cell, unlike competing bulk or single-foci marker assays, allowing evaluation of HR functional heterogeneity across and within patient biopsies. This approach facilitates robust comparisons of HR and foci-based processes across diverse cell populations and patient tissues, enabling scalable, translational research. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=144 SRC="FIGDIR/small/639329v1_ufig1.gif" ALT="Figure 1"> View larger version (33K): org.highwire.dtl.DTLVardef@154d43eorg.highwire.dtl.DTLVardef@3a6fa6org.highwire.dtl.DTLVardef@782daborg.highwire.dtl.DTLVardef@1fe6c28_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 3
- FWCI
- 1.13
- Field percentile
- top 24%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Direct prediction of Homologous Recombination Deficiency from routine histology in ten different tumor types with attention-based Multiple Instance Learning: a development and validation study
Chiara Maria Lavinia Loeffler, Omar S. M. El Nahhas, … Jakob Nikolas Kather·medRxiv·Mar 8, 2023
- DirectHRD enables sensitive scar-based classification of homologous recombination deficiency (HRD)
Ruolin Liu, Eugenia Roberts, … Viktor A. Adalsteinsson·Nucleic Acids ResearchPeer-reviewed·Apr 17, 2025
- Deep Learning identifies new morphological patterns of Homologous Recombination Deficiency in luminal breast cancers from whole slide images.
T. Lazard, G. Bataillon, … A. Salomon·bioRxiv·Sep 10, 2021
- HRD-One: CLINICAL VALIDATION AND PERFORMANCE ASSESSMENT. Comparison between Myriad's myChoice(R), SOPHiA GENETICS SOPHiA Homologous Recombination Solution(R) and AmoyDx HRD Focus Panel(R)
Rodrigo Guarischi‐Sousa, José Eduardo Kroll, … Guilherme Lopes Yamamoto·medRxiv·Mar 28, 2023
- A deep learning approach for improved detection of homologous recombination deficiency from shallow genomic profiles
G. Andre, T. Coletta, … Z. Xu·bioRxiv·Jul 6, 2022
- Homologous recombination deficiency prediction from whole slide images using label refinement and foundation-model benchmarking in ovarian cancer
Nauman Ali Shah, Makhdoom Sarwar, Ehsan Ullah·bioRxiv·Jun 30, 2026